ContractProject Cooperation Framework Agreement • May 13th, 2015
Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this joint announcement.
EXHIBIT 10.21 PROJECT COOPERATION FRAMEWORK AGREEMENT PARTY A: SHANGHAI EVEREASE COMMUNICATION COMPANY Legal Representative: Jason Nanchun Jiang Address: Floor 28-30, Zhaofeng World Trade Mansion, No.369, Jiangsu Road, Shanghai Telephone:...Project Cooperation Framework Agreement • June 14th, 2005 • Focus Media Holding LTD
PT Vale and Partners Signed Project Cooperation Framework Agreement for the Bahodopi Nickel Processing FacilityProject Cooperation Framework Agreement • June 24th, 2021
Jakarta, June 24, 2021 – PT Vale Indonesia tbk (“PTVI”) together with two partners (“Partners”), Taiyuan Iron & Steel (Group) Co., Ltd (“Taigang”) and Shandong Xinhai Technology Co., Ltd (“Xinhai”), today has signed a Project Cooperation Framework Agreement document (“Agreement”) for the Bahodopi Nickel Processing Facility Project (“Project”).
PT Vale and Partners Signed Project Cooperation Framework Agreement for the Bahodopi Nickel Processing FacilityProject Cooperation Framework Agreement • June 24th, 2021
Jakarta, June 24, 2021 – PT Vale Indonesia Tbk (“PTVI”) together with two partners (“Partners”), Taiyuan Iron & Steel (Group) Co., Ltd (“TISCO”) and Shandong Xinhai Technology Co., Ltd (“Xinhai”), today has signed a Project Cooperation Framework Agreement document (“Agreement”) for the Bahodopi Nickel Processing Facility Project (“Project”).
PROjECT COOPERATION FRAMEWORK AGREEMENT WITH COUNTRY GARDEN HOLDINGS COMPANY LIMITEDProject Cooperation Framework Agreement • June 21st, 2013
This announcement is made by Haichang Ocean Park Holdings Ltd. (the “Company”, together with the subsidiaries, the “Group”) on a voluntary basis. The purpose of this announcement is to keep the shareholders and potential investors of the Company informed of the latest business development of the Group.
Project Cooperation Framework AgreementProject Cooperation Framework Agreement • August 17th, 2023 • Jyong Biotech Ltd. • Pharmaceutical preparations
Health Ever Bio-Tech Co., Ltd. was established in 2002 with a paid-in capital of NT$730 million; its operating headquarters are located in Taiwan (Taipei City, Bali District of New Taipei City and Yilan County). It is the only company in the world to develop new botanical medicines for men with enlarged prostate. At present, the company has 4 varieties of new medicines in clinical stage. MCS-2 is a new botanical medicine for the treatment of prostatic hypertrophy independently developed by the company. It has completed Phase III clinical trials in humans by the US FDA and Taiwan Medicine Administration, which has successfully completed the unblinding procedures of US FDA in April 2017 and Taiwan Medicine Administration in May 2016; and completed the US Pre-NDA (Pre-Medicine License Application Meeting) in the first quarter of 2018; it will submit a medicine license application to the United States in the first quarter of 2019. The new medicine is expected to be launched in 2022. In mai
